rs1005300
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.
|
28025584 |
2017 |
rs10507419
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.
|
28679651 |
2017 |
rs10799599
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.
|
28025584 |
2017 |
rs4487645
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.
|
28025584 |
2017 |
rs6752376
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.
|
28679651 |
2017 |
rs7820212
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.
|
28679651 |
2017 |
rs79419269
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.
|
28025584 |
2017 |
rs9344
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.
|
28679651 |
2017 |
rs9344
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
In AL amyloidosis, rs9344 at the splice site of cyclin D1, promoting translocation (11;14), reached the highest significance, P=7.80 × 10<sup>-11</sup>; the SNP was only marginally significant in MM.
|
28025584 |
2017 |
rs387907272
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We identified the MYD88 L265P somatic variant in cases with WM (39/42), MGUS (8/18), NHL (14/41, including 4/13 diffuse large B cell lymphoma (DLBCL), 1/8 mucosa-associated lymphoid tissue, 3/6 splenic marginal zone lymphoma (SMZL), 1/4 chronic lymphocytic leukemia, 2/3 nodal marginal zone lymphoma (NMZL), 1/2 mantle cell lymphoma, 1 Burkitt lymphoma, and 1 B cell NHL that could not be classified), primary AL (2/2), and IgM-PN (1/1).
|
28280994 |
2017 |
rs76992529
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
|
19781421 |
2009 |
rs121909612
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The mutation underlying Glu526Val fibrinogen alpha-chain amyloidosis is incompletely penetrant and has a variable phenotype that can clinically mimic AL amyloidosis.
|
10825402 |
2000 |